Demand drops for Johnson & Johnson COVID-19 vaccine
Clip: 05/18/2021 | 4m 8s | Video has closed captioning.
Apparently fewer people are asking for Johnson & Johnson's COVID-19 vaccine even though it's a convenient, "one-and-done" shot. The lingering lack of confidence in J&J's product follows its 10-day suspension over a rare but serious blood clotting problem that affected mostly women. Public health experts say the vaccine's still very useful in reaching out to underserved communities.
Problems Playing Video? | Closed Captioning